R&D | April 22, 2026
Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
Pharma giant targets new standards of care
Pharma giant targets new standards of care
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Move comes amid rising regulatory pressures
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By cutting pain crises & boosting haemoglobin
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Subscribe To Our Newsletter & Stay Updated
